Jeff Lagasse

By  Jeff Lagasse 03:09 pm September 8, 2017
Tabula Rasa Healthcare, a healthcare technology company focused on medication safety, is hoping to pump up its technological might, and this week took a step in that direction by completing its acquisition of SinfoníaRx, a provider of Medication Therapy Management technology and services for Medicare, Medicaid, and Commercial Health plans.   SinfoníaRx has been growing pretty rapidly of late....
By  Jeff Lagasse 11:49 am September 8, 2017
With Hurricane Irma bearing down on Florida and the surrounding islands, those caught in the path of the destructive category 5 storm may feel like they need to reach out and talk to someone, particularly if they have a health issue that needs immediate attention. Luckily, a number of health plans realize this and are offering help lines and other support as Irma cuts a swath through the American...
By  Jeff Lagasse 12:01 pm September 7, 2017
Boston-based Antidote Technologies expects it will soon be able to accelerate the development of capabilities for its trial matching platform – including precision medicine and EHR matching. That’s because the company has just entered into an agreement for an $11 million funding round led by Merck Global Health Innovation Fund, and joined by existing investors Smedvig Capital and Octopus Ventures...
By  Jeff Lagasse 09:42 am September 7, 2017
Harvard Health Publications, which harnesses the expertise of more than 11,000 Harvard Medical School faculty clinicians to create patient health engagement materials, is collaborating with Outcome Health. The latter seeks to improve patient outcomes by providing health intelligence and information at the moment of care using technology. The partnership will bring Harvard Medical School’s...
By  Jeff Lagasse 02:00 pm September 6, 2017
Truveris, a healthcare technology company focused cloud-based data analytics solutions for the $450 billion prescription benefits industry, today announced that the company has secured $25 million in a new round of funding to accelerate its growth strategies.   The Series D round was led by McKesson Ventures, and included Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, and...
By  Jeff Lagasse 10:05 am September 6, 2017
Update: A previous version of this post included out-of-date information from an older draft of Talkspace's press release.  Online therapy company Talkspace is now flush with $31 million in new financing. Qumra Capital, an Israel-based growth stage fund, led the Series C round and was joined by existing investors Norwest Venture Partners, Spark Capital, SoftBank, Compound Ventures, and FirstTime...
By  Jeff Lagasse 03:11 pm September 5, 2017
Healthcare analytics and decision support company Health Catalyst has just introduced a new engineering approach called the Health Catalyst Data Operating System, or DOS (not to be confused with the ancient PC operating system). DOS combines the features of data warehousing, clinical data repositories and health information exchanges into a single technology platform. Healthcare trails all...
By  Jeff Lagasse 02:03 pm September 5, 2017
Behavioral health technology company AbleTo secured $36.6 million in financing last week, led by Bain Capital Ventures, and all of its existing investors -- 406 Ventures, Sandbox Industries, HLM Venture Partners, and Horizon Healthcare Services -- participated in the Series B round as well. Strategic investor Aetna also chipped in.   With the fresh investment, AbleTo plans on turbocharging the...
By  Jeff Lagasse 11:36 am September 5, 2017
Swedish outfit Aifloo, which produces a smart wristband powered by artificial intelligence, has raised $6 million (€5.1 million) in new funding, according to TechCrunch. EQT Ventures led the Series A funding round.   Seniors are the target demographic for the wristband, as it’s designed to improve the quality of their lives and make things easier for caregivers. The product is equipped with...
By  Jeff Lagasse 02:13 pm September 1, 2017
One of the biggest hurdles to addressing the opioid crisis in the US is knowing what alternative, non-opioid medications to prescribe for the treatment of chronic pain. Physicians struggle with a complex, patchwork system of state guidelines and regulations that vary with each particular state.   Enter Avella, a Phoenix-based specialty pharmacy that has just launched a new mobile app aimed at...